A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance

Hybrid therapy is a novel two-step treatment achieving a high eradication rate for Helicobacter pylori infection. Currently, whether this new therapy achieves a higher eradication rate than bismuth quadruple therapy remains an unanswered question. The aim of this prospective, randomized comparative...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Antimicrob Agents Chemother
Κύριοι συγγραφείς: Tsay, Feng-Woei, Wu, Deng-Chyang, Yu, Hsien-Chung, Kao, Sung-Shuo, Lin, Kung-Hung, Cheng, Jin-Shiung, Wang, Huay-Min, Chen, Wen-Chi, Sun, Wei-Chih, Tsai, Kuo-Wang, Hsu, Ping-I
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology 2017
Θέματα:
Clinical Therapeutics
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655074/
https://ncbi.nlm.nih.gov/pubmed/28807915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00140-17
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια